Cel
Traditional preclinical discovery methods, particularly for target validation, poorly predict drug efficacy, causing a high attrition rate in costly late-stage clinical trials. The PREDECT consortium will focus on complex but transferable, next generation in vitro and in vivo models for breast, prostate and lung cancers. Models will be investigated for their improved potential to validate novel therapeutic targets. Known targets, in canonical pathways, will be interrogated for induction of phenotypic, proteomic and transcriptomic changes using inhibitors. A strategy of seeking a ‘dynamic reciprocity’ of concordance between the steady and perturbed states of in vitro complex cultures, tissue slices and in vivo tumour models will be pursued by systems biology analyses. Comparison with historic gene expression and genomic data from relevant clinical materials should permit the emergence of faithful models for target validation and beyond.
PREDECT is coordinated by Servier and AstraZeneca, and the managing entity of IMI JU funding is the University of Helsinki. The team assembles world-class biologists, clinicians and computational scientists from 8 prestigious EU institutes, 3 SMEs and 8 EFPIA members to develop and critically assess models for target validation. The interaction between pharmaceutical and academic participants will be proactive, through postdoc co-supervision and work package co-piloting.
We propose to develop and generate a repository of advanced complex models in 3 complementary areas: (i) in vitro 2D/3D organotypic (co-)cultures, stirred bioreactor aggregates and tissue slice systems; (ii) novel (orthotopic) grafts of human and mouse tumour samples; and (iii) genetically-engineered and mosaic mouse models. The deliverables of PREDECT are expected to shift paradigms in target validation, permitting greater predictivity of drug efficacy in patient cohorts.
Dziedzina nauki
Zaproszenie do składania wniosków
IMI-JU-02-2009
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Koordynator
91190 GIF-SUR-YVETTE
Francja
Zobacz na mapie
Uczestnicy (20)
00014 Helsingin Yliopisto
Zobacz na mapie
Zakończenie uczestnictwa
02044 VTT ESPOO
Zobacz na mapie
1015 Lausanne
Zobacz na mapie
7610001 Rehovot
Zobacz na mapie
2781-901 Oeiras
Zobacz na mapie
6525 XZ Nijmegen
Zobacz na mapie
3015 GD Rotterdam
Zobacz na mapie
51005 Tartu
Zobacz na mapie
79108 Freiburg
Zobacz na mapie
00290 Helsinki
Zobacz na mapie
151 85 Sodertaelje
Zobacz na mapie
13353 Berlin
Zobacz na mapie
02200 Espoo
Zobacz na mapie
4070 Basel
Zobacz na mapie
Zakończenie uczestnictwa
00144 Roma
Zobacz na mapie
55218 Ingelheim
Zobacz na mapie
70376 Stuttgart
Zobacz na mapie
2340 Beerse
Zobacz na mapie
CF24 0DE Cardiff
Zobacz na mapie
60064 North Chicago Il
Zobacz na mapie